Progenics Pharmaceuticals, Inc. (PGNX)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
2 Small Biopharma Stocks on the Move

2 Small Biopharma Stocks on the Move

The oversold biotech sector is recovering.

A Small Biotech Sells for Less Than Cash

A Small Biotech Sells for Less Than Cash

And yet, Endocyte has a deep pipeline.

Biotech Stocks Are Beginning to Stir

Biotech Stocks Are Beginning to Stir

I am starting to get more confident that the small caps are ready to bounce.

Gilead Leads a Biotech Rally

Gilead Leads a Biotech Rally

The sector saw solid performance this week as the biotech juggernaut mounted a long-overdue rally.

Gilead Leads a Biotech Rally

Gilead Leads a Biotech Rally

The sector saw solid performance this week as the biotech juggernaut mounted a long-overdue rally.

Don't Miss These 3 Biotech Stocks

Don't Miss These 3 Biotech Stocks

Investors have been distracted by the Fed, and that's a shame.

These 2 Small Caps Enjoy Strong Growth

These 2 Small Caps Enjoy Strong Growth

Synergy and Progenics have been kind to my portfolio.

Revisiting 2 Little Biotech Gems

Revisiting 2 Little Biotech Gems

They both have even more upside momentum. 

Partnerships Lift Small Caps

Partnerships Lift Small Caps

Watch for small biotechs partnering with bigger firms.

A Small, but Promising Biotech Stock

A Small, but Promising Biotech Stock

This small cap has some interesting technology.

Betting the Underdog Can Be Profitable

Betting the Underdog Can Be Profitable

Winners don't always pay the best.

The Frantic Hunt for Performance

It's been a tremendous challenge just to keep pace.

Two Small-Cap Biotechnology Gems

Two Small-Cap Biotechnology Gems

For speculative investors.

Assessing Third-Quarter Earnings Surprises

Assessing Third-Quarter Earnings Surprises

It is time look at the quarter's pockets of exceptional strength and weakness.

Volatile Market Presents Mixed Bag

Volatile Market Presents Mixed Bag

I see bargains, but would avoid some of the big-name momentum stocks.

Potential Biotech Play

Potential Biotech Play

Andrew believes that a big trade on PGNX might be an opportunity for retail traders. He thinks that if the stock drops in price to around $2, you may want to consider buying some call options.